King Names Markison President & CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
Brian Markison was also elected to the company's board of directors. He joined King as chief operating officer in March, and was named acting president and CEO in May.
You may also be interested in...
Novavax Reacquires Estrasorb From King
The company gets back full rights to the topical estrogen emulsion and picks up 50 reps from King. The transaction stems from King’s decision to exit the women’s health market.
Novavax Reacquires Estrasorb From King
The company gets back full rights to the topical estrogen emulsion and picks up 50 reps from King. The transaction stems from King’s decision to exit the women’s health market.
King Names Markison Acting CEO; President Macione Steps Down
Chief Operating Officer Brian Markison will assume the duties of CEO Jefferson Gregory and President Kyle Macione, who are both leaving the company. King taps former pharma industry exec Ted Wood as chairman.